In recommendations by the EASL-EASD-EASO Clinical Practice Guidelines [12] the performance of CK-18 M30 to differentiate NASH from NAFL was judged modest, as per data from a meta-analysis of 11 studies [13]. The gene discussed is KRT18; the disease is metabolic dysfunction-associated steatohepatitis.